Shahgholian Nahid, Hashemi Maryam Sadat, Shahidi Shahrzade
Department of Critical Care, Isfahan Kidney Disease Research Center, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
PhD Candidate in Nursing, Isfahan University of Medical Sciences, Isfahan, Iran.
Iran J Nurs Midwifery Res. 2015 Jan-Feb;20(1):12-6.
Hypertension is very common in patients with end-stage renal disease and accelerates cardiovascular morbidity and mortality. The most important factor in achieving normal blood pressure in these patients is reaching dry weight. Sodium and extracellular fluid balance play a vital role in this regard. Considering the lack of consensus about the efficacy of stepwise sodium profile and individualized dialysate sodium, this study aimed to determine the superior method for blood pressure control in hemodialysis patients.
In a quasi-experimental study, patients satisfying the inclusion criteria were enrolled through convenience sampling. The patients were randomly assigned to two groups of stepwise sodium profile and individualized dialysate sodium. Information record form was used for data collection. Data were analyzed with paired and independent t-test and descriptive statistics using SPSS for Windows 20.0.
Patients in the two groups were similar in qualitative and quantitative background variables. While systolic blood pressure significantly decreased following hemodialysis with individualized dialysate sodium (P < 0.001), there was no significant difference between pre- and post-dialysis systolic blood pressure values using stepwise sodium profile (P = 0.060). Individualized dialysate sodium caused greater change in the mean systolic blood pressure than stepwise sodium profile did (P = 0.040). Pre- and post-dialysis diastolic blood pressure values showed significant differences in both groups (P < 0.001 using individualized dialysate sodium and P = 0.009 using stepwise sodium profile). However, the mean changes in diastolic blood pressure of the two groups were not significantly different (P = 0.295).
We found no significant difference in interdialytic weight gain and blood pressure control by the two methods. The change in systolic blood pressure was lower in the stepwise profile method than in the individualized dialysate sodium method, and this method did not cause interdialytic hypertension. So, by adjusting the dialysis solution with regard to plasma sodium levels, lead to more blood pressure control. Meanwhile, the two groups were not significantly different in the mean changes of diastolic blood pressure.
高血压在终末期肾病患者中非常常见,会加速心血管疾病的发病率和死亡率。在这些患者中实现正常血压的最重要因素是达到干体重。钠和细胞外液平衡在这方面起着至关重要的作用。鉴于对于逐步调整钠浓度曲线和个体化透析液钠浓度的疗效缺乏共识,本研究旨在确定血液透析患者血压控制的更佳方法。
在一项半实验性研究中,通过便利抽样纳入符合纳入标准的患者。将患者随机分为逐步调整钠浓度曲线组和个体化透析液钠浓度组。使用信息记录表收集数据。使用适用于Windows 20.0的SPSS进行配对和独立t检验以及描述性统计分析数据。
两组患者在定性和定量背景变量方面相似。使用个体化透析液钠进行血液透析后收缩压显著降低(P < 0.001),而使用逐步调整钠浓度曲线时透析前和透析后收缩压值无显著差异(P = 0.060)。个体化透析液钠导致平均收缩压的变化大于逐步调整钠浓度曲线(P = 0.040)。两组透析前和透析后的舒张压值均显示出显著差异(使用个体化透析液钠时P < 0.001,使用逐步调整钠浓度曲线时P = 0.009)。然而,两组舒张压的平均变化无显著差异(P = 0.295)。
我们发现两种方法在透析间期体重增加和血压控制方面无显著差异。逐步调整钠浓度曲线方法中收缩压的变化低于个体化透析液钠方法,且该方法未导致透析间期高血压。因此,通过根据血浆钠水平调整透析液,可实现更好的血压控制。同时,两组舒张压的平均变化无显著差异。